These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25755173)

  • 1. Identification of novel biomarker candidates for immunohistochemical diagnosis to distinguish low-grade chondrosarcoma from enchondroma.
    Lai X; Chen S
    Proteomics; 2015 Jul; 15(13):2358-68. PubMed ID: 25755173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of MicroRNA biomarkers to distinguish enchondroma from low-grade chondrosarcoma.
    Zhang L; Yang M; Mayer T; Johnstone B; Les C; Frisch N; Parsons T; Mi QS; Gibson G
    Connect Tissue Res; 2017 Mar; 58(2):155-161. PubMed ID: 27267924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
    Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
    Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma.
    Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S
    Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR differentiation of low-grade chondrosarcoma from enchondroma.
    Choi BB; Jee WH; Sunwoo HJ; Cho JH; Kim JY; Chun KA; Hong SJ; Chung HW; Sung MS; Lee YS; Chung YG
    Clin Imaging; 2013; 37(3):542-7. PubMed ID: 23041161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
    Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periostin is a novel histological biomarker for the diagnosis of chondroid tumor.
    Kim D; Jeong JY; Han MH; Chae J; Park I; Yoon J; Kyung H; Kim HJ; Jeong W
    Transl Cancer Res; 2021 Jan; 10(1):434-444. PubMed ID: 35116273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
    Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
    Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of connective tissue growth factor in cartilaginous tumors.
    Shakunaga T; Ozaki T; Ohara N; Asaumi K; Doi T; Nishida K; Kawai A; Nakanishi T; Takigawa M; Inoue H
    Cancer; 2000 Oct; 89(7):1466-73. PubMed ID: 11013359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of estrogen receptors in chondrosarcomas and enchondromas.
    Grifone TJ; Haupt HM; Podolski V; Brooks JJ
    Int J Surg Pathol; 2008 Jan; 16(1):31-7. PubMed ID: 18203781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
    Joseph NM; McGill KC; Horvai AE
    Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study.
    Lisson CS; Lisson CG; Flosdorf K; Mayer-Steinacker R; Schultheiss M; von Baer A; Barth TFE; Beer AJ; Baumhauer M; Meier R; Beer M; Schmidt SA
    Eur Radiol; 2018 Feb; 28(2):468-477. PubMed ID: 28884356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMP3, CDK4, MDM2 and β-catenin expression in Enchondroma and Central Chondrosarcoma: Diagnostic and prognostic utility.
    Losada DM; Etchebehere M; Cintra FF; Amstalden EMI
    Clinics (Sao Paulo); 2024; 79():100483. PubMed ID: 39368400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel biomarker and therapeutic target candidates for diagnosis and treatment of follicular carcinoma.
    Lai X; Umbricht CB; Fisher K; Bishop J; Shi Q; Chen S
    J Proteomics; 2017 Aug; 166():59-67. PubMed ID: 28709933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
    Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
    Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadd45β expression in chondrosarcoma: a pilot study for diagnostic and biological implications in histological grading.
    Zenmyo M; Tanimoto A; Sakakima H; Yokouchi M; Nagano S; Yamamoto T; Ishido Y; Komiya S; Ijiri K
    Diagn Pathol; 2010 Oct; 5():69. PubMed ID: 20942912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
    van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can imaging criteria distinguish enchondroma from grade 1 chondrosarcoma?
    Crim J; Schmidt R; Layfield L; Hanrahan C; Manaster BJ
    Eur J Radiol; 2015 Nov; 84(11):2222-30. PubMed ID: 26220916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAS inclusions, immunoreactive tenascin and proliferative activity in low-grade chondrosarcomas.
    Ranty ML; Michot C; Le Pessot F; Hellot MF; Biga N; Dujardin FH; Simonet J; Billerey C; Metayer J
    Pathol Res Pract; 2003; 199(1):29-34. PubMed ID: 12650515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Novel Biomarker and Therapeutic Target Candidates for Diagnosis and Treatment of Follicular Adenoma.
    Lai X; Chen S
    Cancer Genomics Proteomics; 2015; 12(6):271-81. PubMed ID: 26543076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.